意大利儿科胃肠病学和肝脏病学在 COVID-19 前后：SIGENP 吸取的经验教训和管理变化。
Pediatric Gastroenterology and Hepatology in Italy before and after the COVID-19: Lessons learned and management changes by SIGENP.
机构信息
Pediatric Gastroenterology and Cystic Fibrosis Unit, Department of Human Pathology in Adulthood and Childhood "G. Barresi", University of Messina, Messina, Italy.
Department of Pediatrics, Woman's & Children's University Hospital of Verona, 37126, Verona, Italy.
出版信息
Ital J Pediatr. 2023 Jan 26;49(1):15. doi: 10.1186/s13052-023-01418-7.
Around the world, the 2019 Coronavirus disease (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has raised serious public health problems and major medical challenges. The Italian Society of Pediatric Gastroenterology, Hepatology and Nutrition (SIGENP) published several papers on the impact of COVID-19 on the current management, diagnosis, and treatment of acute and chronic gastrointestinal, hepatic, immune-mediated, and functional disorders. The present article summarizes the most relevant SIGENP reports and consensus during and after the peak of the COVID-19 outbreak, including the diagnosis and treatment of inflammatory bowel disease (IBD), indications and timing of digestive endoscopy, and insights into the novel hepatitis.
在全球范围内，由严重急性呼吸系统综合症冠状病毒 2 型（SARS-CoV-2）引起的 2019 年冠状病毒病（COVID-19）引发了严重的公共卫生问题和重大的医学挑战。意大利儿科胃肠病学、肝病学和营养学学会（SIGENP）发表了多篇关于 COVID-19 对当前急性和慢性胃肠、肝、免疫介导和功能性疾病的管理、诊断和治疗的影响的论文。本文总结了 COVID-19 爆发期间和之后 SIGENP 的最相关报告和共识，包括炎症性肠病（IBD）的诊断和治疗、消化内镜的适应证和时机，以及对新型肝炎的见解。
Zotero 插件